OOIR: Observatory of International Research

Papers

(The TQCC of European Respiratory Review is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies	146
Sex and gender in asthma	133
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management	106
Post-acute COVID-19 syndrome	101
COVID-19 pneumonia: pathophysiology and management	85
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis	81
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)	76
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea	76
Minimal clinically important difference for asthma endpoints: an expert consensus report	73
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes	69
Developments in lung transplantation over the past decade	68
Clinical significance and applications of oscillometry	65
Mitochondrial dysfunction in lung ageing and disease	56
Asthma and COVID-19: an update	56
The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review	50
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	49
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?	49
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	48
Bidirectional relationships of comorbidity with obstructive sleep apnoea	48
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review	47
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	45
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	44
Birt–Hogg–Dubé syndrome	43
Artificial intelligence in pulmonary medicine: computer vision, predictive model and COVID-19	43
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	43

COVID-19 and tuberculosis: the double whammy of respiratory pathogens	41
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	40
Chronic cough: new insights and future prospects	39
Recent developments in the treatment of small cell lung cancer	38
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	38
Lung transplantation for interstitial lung disease	38
Current evidence for COVID-19 therapies: a systematic literature review	37
Lung cancer is also a hereditary disease	37
Update on biology and management of mesothelioma	35
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment	35
Diagnosis, course and management of hypersensitivity pneumonitis	34
Just breathe: a review of sex and gender in chronic lung disease	34
Systematic review and meta-analysis of residential radon and lung cancer in never-smokers	34
Management of tracheo-oesophageal fistula in adults	33
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research	32
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	32
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women	32
Noninfectious pulmonary complications of haematopoietic stem cell transplantation	32
Fibrotic interstitial lung diseases and air pollution: a systematic literature review	32
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis	31
Eosinophils and eosinophilic immune dysfunction in health and disease	31
Sex and gender in pulmonary arterial hypertension	31
Prevalence of α₁-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review	30
Lung complications of Sjogren syndrome	30
Genetic disorders of the surfactant system: focus on adult disease	29
Influenza vaccination: protecting the most vulnerable	29
Chitotriosidase: a marker and modulator of lung disease	29
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis	29
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	29
Contemporary issues in the implementation of lung cancer screening	29
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	29
Extracellular matrix remodelling in COPD	29
Desquamative interstitial pneumonia: a systematic review of its features and outcomes	29
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives	29
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis	28
Pulmonary hypertension phenotypes in patients with systemic sclerosis	28
The prevalence and related factors of fatigue in patients with COPD: a systematic review	28
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways	27
Cystic fibrosis-related diabetes and lung disease: an update	27
Post-intubation subglottic stenosis: aetiology at the cellular and molecular level	26
Development and clinical translation of tubular constructs for tracheal tissue engineering: a review	26
Exercise training for lung transplant candidates and recipients: a systematic review	26
Sex and gender in respiratory physiology	25
COPD and acute myocardial infarction	25
Ventilatory efficiency in pulmonary vascular diseases	25
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	25
Structure and function of small airways in asthma patients revisited	25
The radiological diagnosis of bronchiectasis: what's in a name?	24
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	24
Therapeutic bronchoscopy for central airway diseases	24

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?	24
Sex, gender and the pulmonary physiology of exercise	24
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment	24
Current unmet needs and potential solutions to uncontrolled asthma	24
Thoracic ultrasound in the modern management of pleural disease	24
Asthma-COPD overlap: current understanding and the utility of experimental models	23
The clinical value of cardiopulmonary exercise testing in the modern era	23
The role of mucin 1 in respiratory diseases	22
Chronic lung diseases: entangled in extracellular matrix	22
Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis	22
Meta-analysis on short-term exposure to ambient ultrafine particles and respiratory morbidity	22
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	22
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?	22
Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis	21
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis	21
Prognostic factors in chronic hypersensitivity pneumonitis	21
Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis	21
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	21
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	21
Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis	21
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	21
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	20
Early origins of lung disease: towards an interdisciplinary approach	20
The integrated stress response in pulmonary disease	20
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis	20
Severe community-acquired pneumonia	20
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	20
Waterpipe smoking: a review of pulmonary and health effects	19
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	19
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	19
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	19